Overcoming the regulatory impasse in stem cell research and advanced therapy medicines in Argentina through shared norms and values

In G. T. Laurie, E. S. Dove & Niamh Nic Shuibhne (eds.), Law and legacy in medical jurisprudence: essays in honour of Graeme Laurie. New York, NY: Cambridge University Press (2022)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Emerging technologies and developing countries: Stem cell research regulation and Argentina.Shawn H. E. Harmon - 2007 - Developing World Bioethics 8 (2):138-150.
On Moral Incoherence and Hidden Battles: Stem Cell Research in Argentina.Arleen Salles Florencia Luna - 2010 - Developing World Bioethics 10 (3):120-128.
On moral incoherence and hidden battles: Stem cell research in argentina.Florencia Luna & Arleen Salles - 2010 - Developing World Bioethics 10 (3):120-128.
Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives.Mohammad Firdaus Bin Abdul Aziz, Michael Morrison & Jane Kaye - 2018 - New Genetics and Society 37 (1):2-20.
Stem Cells Therapy and Research. Benefits and Ethical Challences.Nicolae Ovidiu Grad, Ionel Ciprian Pop & Ion Aurel Mironiuc - 2012 - Journal for the Study of Religions and Ideologies 11 (32):190-205.
Motivating Values and Regulatory Models for Emerging Technologies: Stem Cell Research Regulation in Argentina and the United Kingdom.S. Harmon - 2008 - In Michael Freeman (ed.), Law and Bioethics: Current Legal Issues Volume 11. Oxford University Press.
Motivating values and regulatory models for emerging technologies : stem cell research regulation in Argentina and the United Kingdom.Shawn H. E. Harmon - 2008 - In Michael D. A. Freeman (ed.), Law and Bioethics / Edited by Michael Freeman. Oxford University Press.
The Ethics of Moral Compromise for Stem Cell Research Policy.Zubin Master & G. K. D. Crozier - 2012 - Health Care Analysis 20 (1):50-65.
Characterisation of normal and cancer stem cells: One experimental paradigm for two kinds of stem cells.Jean-François Mayol, Corinne Loeuillet, Francis Hérodin & Didier Wion - 2009 - Bioessays 31 (9):993-1001.
The Regulation of Human Germline Intervention in Taiwan.Daniel Fu-Chang Tsai - 2019 - In Jochen Taupitz & Silvia Deuring (eds.), Rechtliche Aspekte der Genom-Editierung an der Menschlichen Keimbahn : A Comparative Legal Study. Springer Berlin Heidelberg. pp. 429-437.
A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research.P. Patel - 2006 - Journal of Medical Ethics 32 (4):235-239.
Prospects and Problems of Stem Cell Research in Bangladesh: Can Equity and Justice be Maintained in the Context of Public Health Demand?Abu Sadat Mohammad Nurunnabi - 2016 - Eubios Journal of Asian and International Bioethics 26 (3):117-124.
Fraudsters operate and officialdom turns a blind eye: a proposal for controlling stem cell therapy in China.Li Jiang & Bing He Dong - 2016 - Medicine, Health Care and Philosophy 19 (3):403-410.
Emerging Regulatory Issues for Human Stem Cell Medicine1.Kathleen Liddell & Susan Wallace - 2005 - Genomics, Society and Policy 1 (1):1-20.
Breaches in good regulatory practice – the HFEA policy on compensated egg sharing for stem cell research.S. Devaney - 2008 - Clinical Ethics 3 (1):20-24.

Analytics

Added to PP
2023-12-24

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references